154 related articles for article (PubMed ID: 12051639)
1. Effect of prolonged formalin fixation on the immunohistochemical reactivity of breast markers.
Arber DA
Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):183-6. PubMed ID: 12051639
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 in formalin-fixed breast carcinoma cell block preparations: correlation of results to corresponding tissue block (needle core and excision) samples.
Kinsella MD; Birdsong GG; Siddiqui MT; Cohen C; Hanley KZ
Diagn Cytopathol; 2013 Mar; 41(3):192-8. PubMed ID: 22611048
[TBL] [Abstract][Full Text] [Related]
3. Inadequate formalin fixation decreases reliability of p27 immunohistochemical staining: probing optimal fixation time using high-density tissue microarrays.
De Marzo AM; Fedor HH; Gage WR; Rubin MA
Hum Pathol; 2002 Jul; 33(7):756-60. PubMed ID: 12196928
[TBL] [Abstract][Full Text] [Related]
4. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.
Tan P; Cady B; Wanner M; Worland P; Cukor B; Magi-Galluzzi C; Lavin P; Draetta G; Pagano M; Loda M
Cancer Res; 1997 Apr; 57(7):1259-63. PubMed ID: 9102210
[TBL] [Abstract][Full Text] [Related]
5. Immunostaining of estrogen receptor, progesterone receptor, MIB1 antigen, and c-erbB-2 oncoprotein in cytologic specimens: a simplified method with formalin fixation.
Suthipintawong C; Leong AS; Chan KW; Vinyuvat S
Diagn Cytopathol; 1997 Aug; 17(2):127-33. PubMed ID: 9258620
[TBL] [Abstract][Full Text] [Related]
6. Short-term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma.
Prasad R; Boland GP; Cramer A; Anderson E; Knox WF; Bundred NJ
Cancer; 2003 Dec; 98(12):2539-46. PubMed ID: 14669271
[TBL] [Abstract][Full Text] [Related]
7. Delay to formalin fixation effect on breast biomarkers.
Khoury T; Sait S; Hwang H; Chandrasekhar R; Wilding G; Tan D; Kulkarni S
Mod Pathol; 2009 Nov; 22(11):1457-67. PubMed ID: 19734848
[TBL] [Abstract][Full Text] [Related]
8. The effects of under 6 hours of formalin fixation on hormone receptor and HER2 expression in invasive breast cancer: a systematic review.
Kalkman S; Barentsz MW; van Diest PJ
Am J Clin Pathol; 2014 Jul; 142(1):16-22. PubMed ID: 24926080
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Evaluation of Ki-67 and Comparison with Clinicopathologic Factors in Breast Carcinomas.
Aman NA; Doukoure B; Koffi KD; Koui BS; Traore ZC; Kouyate M; Toure I; Effi AB
Asian Pac J Cancer Prev; 2019 Jan; 20(1):73-79. PubMed ID: 30678383
[TBL] [Abstract][Full Text] [Related]
10. Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial.
Feldt M; Bjarnadottir O; Kimbung S; Jirström K; Bendahl PO; Veerla S; Grabau D; Hedenfalk I; Borgquist S
J Transl Med; 2015 Apr; 13():133. PubMed ID: 25925673
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.
Avci N; Deligonul A; Tolunay S; Cubukcu E; Fatih Olmez O; Ulas A; Hartavi M; Kurt E; Evrensel T
J BUON; 2015; 20(1):45-9. PubMed ID: 25778295
[TBL] [Abstract][Full Text] [Related]
12. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX
Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532
[TBL] [Abstract][Full Text] [Related]
13. ER, PR, and Her2 immunocytochemistry on cell-transferred cytologic smears of primary and metastatic breast carcinomas: a comparison study with formalin-fixed cell blocks and surgical biopsies.
Ferguson J; Chamberlain P; Cramer HM; Wu HH
Diagn Cytopathol; 2013 Jul; 41(7):575-81. PubMed ID: 22807465
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
[TBL] [Abstract][Full Text] [Related]
15. The effect of tamoxifen on expression of ER, PR, Cerb-B2, and ki-67 in C3H mice spontaneous breast cancer model and the relation with chemotherapeutic effect.
Li X; Zhang S; Liu W; Li H
Cell Biochem Biophys; 2014 Dec; 70(3):1875-9. PubMed ID: 25168102
[TBL] [Abstract][Full Text] [Related]
16. The effect of 96-hour formalin fixation on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma.
Yildiz-Aktas IZ; Dabbs DJ; Cooper KL; Chivukula M; McManus K; Bhargava R
Am J Clin Pathol; 2012 May; 137(5):691-8. PubMed ID: 22523206
[TBL] [Abstract][Full Text] [Related]
17. Concordance of immunohistochemistry between core needle biopsy and surgical resection of breast cancer.
Kombak FE; Şahin H; Mollamemişoğlu H; Önem İ; Kaya H; Buğdaycı O; Arıbal E
Turk J Med Sci; 2017 Dec; 47(6):1791-1796. PubMed ID: 29306240
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel.
Dede DS; Gumuskaya B; Guler G; Onat D; Altundag K; Ozisik Y
J BUON; 2013; 18(1):57-63. PubMed ID: 23613389
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
Vohra P; Buelow B; Chen YY; Serrano M; Vohra MS; Berry A; Ljung BM
Cancer Cytopathol; 2016 Nov; 124(11):828-835. PubMed ID: 27315045
[TBL] [Abstract][Full Text] [Related]
20. The effect of delay in fixation, different fixatives, and duration of fixation in estrogen and progesterone receptor results in breast carcinoma.
Apple S; Pucci R; Lowe AC; Shintaku I; Shapourifar-Tehrani S; Moatamed N
Am J Clin Pathol; 2011 Apr; 135(4):592-8. PubMed ID: 21411782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
